Qube Research & Technologies (QRT)’s Outset Medical OM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-687	Closed	-$11.4K	–	3766
2024 Q4	$11.4K	Sell	687 -1,035	-60%	-$12.9K	﹤0.01%	3230
2024 Q3	$17.5K	Sell	1,722 -12,152	-88%	-$361K	﹤0.01%	2982
2024 Q2	$801K	Buy	13,874 +11,343	+448%	+$556K	﹤0.01%	1981
2024 Q1	$84.3K	Sell	2,531 -11,018	-81%	-$558K	﹤0.01%	3363
2023 Q4	$1.1M	Buy	+13,549	New	+$1.1M	﹤0.01%	1870
2023 Q2	–	Sell	-3,555	Closed	-$981K	–	2822
2023 Q1	$981K	Buy	+3,555	New	+$1.31M	﹤0.01%	1303
2022 Q3	–	Sell	-680	Closed	-$152K	–	2861
2022 Q2	$152K	Buy	+680	New	+$293K	﹤0.01%	1804
2020 Q4	–	Sell	-710	Closed	-$533K	–	2100
2020 Q3	$533K	Buy	+710	New	+$583K	0.01%	1013

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OM Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Outset Medical (OM) in Q1 2025, closing a stake of 687 shares — an estimated $11.4K sold.

Qube Research & Technologies (QRT) first reported a position in OM in Q3 2020 and held it in 8 quarters. The position peaked at $1.1M in Q4 2023. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

Qube Research & Technologies (QRT) reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 687 Outset Medical shares in Q1 2025, an estimated $11.4K.
Qube Research & Technologies (QRT) first reported a position in Outset Medical in Q3 2020 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s Outset Medical position peaked at $1.1M in Q4 2023.
61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.